Response Pharmaceuticals, Inc., a clinical-stage company focused on weight management and metabolic health in high-risk populations, today announced the early completion of enrollment in a Phase 2 ...
Perhaps, I said, in one post-prandial reverie, I should become a food writer. “You sure you’ve got the chops?” Dupree asked dryly. There was nothing highfalutin or fake about her.